Goodblend Pennsylvania, LLC, is affiliated with the University Pittsburgh School of Medicine in Pittsburgh.
PENNSYLVANIA, USA — The Pennsylvania Department of Health has approved the eighth clinical registrant to be apart of the state’s first-in-the-nation research program for medical marijuana.
Goodblend Pennsylvania, LLC, was the approved registrant and is affiliated with the University of Pittsburgh School of Medicine in Pittsburgh, according to the Department of Health release.
You can read the full press release here:
The Pennsylvania Department of Health today approved the eighth clinical registrant, Goodblend Pennsylvania, LLC, who will be part of the state’s first-in-the-nation research program for medical marijuana. A clinical registrant holds both a medical marijuana grower/processor and a dispensary permit and is affiliated with an approved academic clinical research center.
“We are thrilled that each of our approved academic clinical research centers now has a research contract with a clinical registrant,” Secretary of Health Dr. Rachel Levine said. “Pennsylvania’s medical marijuana program continues to be a leader for the country as we conduct comprehensive research through this program. The work already being done by these partners is providing physicians with more evidence-based research to make clinical decisions for their patients. This is the cornerstone of our program and the key to our clinically-based, patient-focused program for those suffering with cancer, PTSD and other serious medical conditions.”
Goodblend Pennsylvania LLC is affiliated with University of Pittsburgh School of Medicine in Pittsburgh and will join the seven clinical registrants previously approved. Three clinical registrants were approved in June 2019, with four additional clinical registrants approved in February of 2020.
The clinical research program, guided by the Medical Marijuana Act, or Act 43 of 2018, allows for eight clinical registrants who each must hold both